Terms: = Liver cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Clinical Outcome
7 results:
1. Comparison of Baseline
Wu M; Wang Y; Yang Q; Wang X; Yang X; Xing H; Sang X; Li X; Zhao H; Huo L
J Nucl Med; 2023 Oct; 64(10):1532-1539. PubMed ID: 37500263
[TBL] [Abstract] [Full Text] [Related]
2. A predictive model for early therapeutic efficacy of colorectal liver metastases using multimodal MRI data.
Su X; Zhang H; Wang Y
J Xray Sci Technol; 2023; 31(2):357-372. PubMed ID: 36591694
[TBL] [Abstract] [Full Text] [Related]
3. Metabolic Parameters as Predictors for Progression Free and Overall Survival of Patients with Metastatic Colorectal cancer.
Nemeth Z; Wijker W; Lengyel Z; Hitre E; Borbely K
Pathol Oncol Res; 2020 Oct; 26(4):2683-2691. PubMed ID: 32661836
[TBL] [Abstract] [Full Text] [Related]
4.
Sharma R; Wang WM; Yusuf S; Evans J; Ramaswami R; Wernig F; Frilling A; Mauri F; Al-Nahhas A; Aboagye EO; Barwick TD
Radiother Oncol; 2019 Dec; 141():108-115. PubMed ID: 31542317
[TBL] [Abstract] [Full Text] [Related]
5. Increased mean corpuscular volume of erythrocytes during capecitabine treatment: a simple surrogate marker for clinical response.
Arslan C; Aksoy S; Dizdar O; Kurt M; Güler N; Ozisik Y; Güllü I; Altundag K
Tumori; 2011; 97(6):711-6. PubMed ID: 22322836
[TBL] [Abstract] [Full Text] [Related]
6. CYP2C9 and CYP2C19 polymorphic forms are related to increased indisulam exposure and higher risk of severe hematologic toxicity.
Zandvliet AS; Huitema AD; Copalu W; Yamada Y; Tamura T; Beijnen JH; Schellens JH
Clin Cancer Res; 2007 May; 13(10):2970-6. PubMed ID: 17504998
[TBL] [Abstract] [Full Text] [Related]
7. Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation?
Rochat B; Morsman JM; Murray GI; Figg WD; McLeod HL
J Pharmacol Exp Ther; 2001 Feb; 296(2):537-41. PubMed ID: 11160641
[TBL] [Abstract] [Full Text] [Related]
